- Report
- February 2026
- 463 Pages
Global
From €5143EUR$5,850USD£4,490GBP
- Report
- February 2026
- 475 Pages
Global
From €5143EUR$5,850USD£4,490GBP
- Report
- February 2026
- 364 Pages
Global
From €5143EUR$5,850USD£4,490GBP
- Report
- February 2026
- 576 Pages
Global
From €5143EUR$5,850USD£4,490GBP
- Report
- February 2026
- 477 Pages
Global
From €5143EUR$5,850USD£4,490GBP
- Report
- February 2026
- 268 Pages
Global
From €5143EUR$5,850USD£4,490GBP
- Report
- February 2026
- 376 Pages
Global
From €5143EUR$5,850USD£4,490GBP
- Report
- February 2026
- 175 Pages
Global
From €5143EUR$5,850USD£4,490GBP
- Report
- February 2026
- 276 Pages
Global
From €5143EUR$5,850USD£4,490GBP
- Report
- February 2026
- 371 Pages
Global
From €5143EUR$5,850USD£4,490GBP
- Report
- February 2026
- 273 Pages
Global
From €5143EUR$5,850USD£4,490GBP
- Report
- February 2026
- 272 Pages
Global
From €5143EUR$5,850USD£4,490GBP
- Report
- February 2026
- 381 Pages
Global
From €5143EUR$5,850USD£4,490GBP
- Report
- February 2026
- 386 Pages
Global
From €5143EUR$5,850USD£4,490GBP
- Report
- February 2026
- 568 Pages
Global
From €5143EUR$5,850USD£4,490GBP
- Report
- February 2026
- 395 Pages
Global
From €5143EUR$5,850USD£4,490GBP
- Report
- February 2026
- 281 Pages
Global
From €5143EUR$5,850USD£4,490GBP
- Report
- February 2026
- 390 Pages
Global
From €5143EUR$5,850USD£4,490GBP
- Report
- February 2026
- 265 Pages
Global
From €5143EUR$5,850USD£4,490GBP
- Report
- February 2026
- 452 Pages
Global
From €5143EUR$5,850USD£4,490GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more